BioSpace News Archive

GE Healthcare and Theragnostics announce global commercial partnership for late stage PSMA diagnostic for prostate cancer

GE Healthcare and Theragnostics have entered into a global commercial partnership for a new Prostate-Specific Membrane Antigen (PSMA) PET/CT imaging agent.

October 9, 2019
·
3 min read
Helsinn to co-host alongside Recordati Rare Diseases satellite symposium on MF-CTCL diagnosis optimization at European Academy of Dermatology and Venereology Congress 2019

Helsinn announces it will be co-hosting alongside Recordati Rare Diseases, a worldwide leader in rare diseases and orphan drugs, part of Recordati Group, a satellite symposium at the 28th European Academy of Dermatology and Venereology Congress, held this year in Madrid from 9 – 13 October 2019.

October 9, 2019
·
6 min read
Business and Industry Minister announces Stevenage Bioscience Catalyst as one of six new Life Science Opportunity Zones in UK

Nadhim Zahawi MP has announced that Stevenage Bioscience Catalyst (SBC) has been successful in its application to become a Life Science Opportunity Zone.

October 9, 2019
·
3 min read
Business

NBE-Therapeutics Appoints Dr. Steffen Heeger as Chief Medical Officer for Leading The Clinical Development of NBE’s iADC Programs

NBE-Therapeutics AG, a biopharmaceutical company developing best-in-class, immune-stimulatory antibody drug conjugates (iADCs™), announces the appointment of Dr. Steffen Heeger as Chief Medical Officer (CMO).

October 9, 2019
·
3 min read
FDA

FDA Approves Clinuvel’s Scenesse for Extreme Light Sensitivity

Scenesse is an under-the-skin implant. The drug is the company’s only approved product.

October 9, 2019
·
2 min read
·
Mark Terry
Business

Industry Champion Jim Greenwood to Retire Following 2020 Elections

During his 14-year tenure as head of BIO, Greenwood oversaw a significant growth at the organization, more than tripling its size to 176 employees with an 85 million operating budget.

October 9, 2019
·
4 min read
·
Alex Keown
Policy

FDA Boosts Rare Disease Research with $15 Million in Grants

The grants were awarded through the FDA’s Orphan Products Clinical Trials Grants Program that was provided by Congress to specifically encourage the development of treatments for rare diseases.

October 9, 2019
·
3 min read
·
Alex Keown
Genetown

Improving How Neurological Drugs are Developed Using Cell-Type-Specific Analysis

Cerevance, a pharmaceutical company focusing on central nervous system diseases, has developed a new process for peering into the gene expression of specific brain cells.

October 9, 2019
·
8 min read
·
Chelsea Weidman Burke
Business

Avid Bioservices Announces Completion Of Expansion Of Process Development Capabilities And Laboratory Infrastructure

Company to Host Open House to Celebrate Official Launch of Newly Expanded Laboratories

October 9, 2019
·
2 min read
Drug Development

MilliporeSigma Launches ADC ExpressTM Services to Accelerate Pre-clinical Conjugation Candidate Selection

MilliporeSigma introduced its ADC Express TM services for the rapid production of ADCs, which can reduce the time needed to produce development grade constructs for target molecule identification.

October 9, 2019
·
2 min read